CNMD insider transaction filings
CONMED Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen CNMD transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Gallagher John E — Executive Vice President & CFO | Grant/award (A): 35,054 (derivative) @ $0 · Grant/award (A): 26,875 (derivative) @ $0 · Grant/award (A): 30,536 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Martin Celine Christine — Director | Grant/award (A): 5,603 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Mirviss Jeffrey B. — Director | Grant/award (A): 5,603 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Council LaVerne H — Director | Option exercise (M): 668 @ $0 · Grant/award (A): 5,772 (derivative) @ $0 · Option exercise (M): 668 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Schwarzentraub Barbara J — Director | Option exercise (M): 668 @ $0 · Grant/award (A): 5,772 (derivative) @ $0 · Option exercise (M): 668 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Kaye Mark — Director | Option exercise (M): 668 @ $0 · Grant/award (A): 5,772 (derivative) @ $0 · Option exercise (M): 668 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Kelderman Kim — Director | Grant/award (A): 5,772 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Farkas Charles — Director | Option exercise (M): 668 @ $0 · Grant/award (A): 5,772 (derivative) @ $0 · Option exercise (M): 668 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Bronson David M. — Director | Option exercise (M): 668 @ $0 · Grant/award (A): 5,772 (derivative) @ $0 · Option exercise (M): 668 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Beyer Pat — President & CEO | Grant/award (A): 28,145 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4/A | Schabacker Matthew — VP GM Advanced Surgical | Grant/award (A): 17,471 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4/A | Foust Hollie K — General Counsel & Corp Sec | Grant/award (A): 18,563 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4/A | Ferrell John D. — Executive Vice President - HR | Grant/award (A): 16,926 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4/A | Lalomia Brent — Executive VP RA, QA | Grant/award (A): 17,198 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4/A | SHAGORY PETER K — EVP, STRAT & CORP DEVT | Grant/award (A): 16,926 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Lalomia Brent — Executive VP RA, QA | Option exercise (M): 75 @ $0 · Tax withholding (F): 26 @ $39.90 · Option exercise (M): 75 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Schabacker Matthew — VP GM Advanced Surgical | Grant/award (A): 9,827 (derivative) @ $0 · Grant/award (A): 11,646 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Moller Andrew James — VP Corporate Controller | Grant/award (A): 5,896 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Foust Hollie K — General Counsel & Corp Sec | Grant/award (A): 10,919 (derivative) @ $0 · Grant/award (A): 12,940 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Ferrell John D. — Executive Vice President - HR | Grant/award (A): 9,282 (derivative) @ $0 · Grant/award (A): 10,999 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Lalomia Brent — Executive VP RA, QA | Grant/award (A): 9,554 (derivative) @ $0 · Grant/award (A): 11,322 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Pelletier Johonna Marie — Treasurer and VP, Tax | Grant/award (A): 5,896 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Beyer Pat — President & CEO | Grant/award (A): 28,800 (derivative) @ $0 · Grant/award (A): 68,258 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | SHAGORY PETER K — EVP, STRAT & CORP DEVT | Grant/award (A): 9,282 (derivative) @ $0 · Grant/award (A): 10,999 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Kaye Mark — Director | Option exercise (M): 152 @ $0 · Option exercise (M): 152 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Glaze Richard — Chief Information Officer | Sale (S): 257 @ $41.21 | EDGAR |
| 2025-11-21 | 4 | Glaze Richard — Chief Information Officer | Option exercise (M): 375 @ $0 · Tax withholding (F): 118 @ $40.63 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Garner Todd W — Executive Vice President & CFO | Sale (S): 3,500 @ $43 | EDGAR |
| 2025-11-05 | 4 | Foust Hollie K — General Counsel & Corp Sec | Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,114 @ $45.71 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | Garner Todd W — Executive Vice President & CFO | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 2,164 @ $44 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Farkas Charles — Director | Sale (S): 1,103 @ $53.53 · Sale (S): 897 @ $53.51 | EDGAR |
| 2025-09-09 | 4 | Kelderman Kim — Director | Grant/award (A): 500 (derivative) @ $0 · Grant/award (A): 6,227 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Garner Todd W — Executive Vice President & CFO | Sale (S): 598 @ $52.45 | EDGAR |
| 2025-06-04 | 4 | Council LaVerne H — Director | Option exercise (M): 479 @ $0 · Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Schwarzentraub Barbara J — Director | Option exercise (M): 479 @ $0 · Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Kaye Mark — Director | Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Farkas Charles — Director | Option exercise (M): 479 @ $0 · Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Aronson Martha Goldberg — Director | Option exercise (M): 479 @ $0 · Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Concannon Brian — Director | Option exercise (M): 479 @ $0 · Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Bronson David M. — Director | Option exercise (M): 479 @ $0 · Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Farkas Charles — Director | Option exercise (M): 1,000 @ $55.70 · Tax withholding (F): 966 @ $57.69 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Workman John L — Director | Option exercise (M): 479 @ $59.84 · Option exercise (M): 479 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Epinette Stephan — VP GM International | Grant/award (A): 17,144 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | Farkas Charles — Director | Sale (S): 4,000 @ $56.94 | EDGAR |
| 2025-05-01 | 4 | Schabacker Matthew — VP GM Advanced Surgical | Grant/award (A): 31,675 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Garner Todd W — Executive Vice President & CFO | Grant/award (A): 371 @ $57.37 | EDGAR |
| 2025-03-17 | 4 | SHAGORY PETER K — EVP, STRAT & CORP DEVT | Option exercise (M): 4,500 @ $55.42 · Tax withholding (F): 4,316 @ $58.83 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Lalomia Brent — Vice President QA and RA | Option exercise (M): 75 @ $0 · Tax withholding (F): 26 @ $62.74 · Option exercise (M): 75 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Foust Hollie K — General Counsel & Corp Sec | Grant/award (A): 30,738 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Glaze Richard — Chief Information Officer | Grant/award (A): 11,750 (derivative) @ $0 | EDGAR |
Recent 8-K events — CONMED Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CNMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →